Posts Tagged ‘TTBD’

TTBD aims to bring together inventors, investors and industry

The OHSU Technology Transfer & Business Development (TTBD) office is trying to send a clear message: We’ve got some really cool inventions at OHSU, and we’re open for business. Two new articles from the Portland Business Journal have focused on the TTBD office and the importance of commercializing innovations coming out of universities. The first article titled “OHSU conferences aim to bring together inventors, investors and industry,” discussed the office’s efforts to give investors and industry … Read More

Tech Transfer Newsletter: Fall 2014

Check out the latest news in the office of Technology Transfer & Business Development (TTBD) In this issue, we discuss:  An OHSU startup company’s drug that reached FDA approval – Contrave, an anti-obesity drug that is receiving high praises Introducing the OHSU MedTech Alliance – A mechanism for potential investors and industry collaborators to identify OHSU medical technologies Learn more about industry and academic collaborations – What type of agreement is appropriate for you? 2014 TTBD Awards recap … Read More

TTBD Lunch & Learn: Keeping a Lab Notebook, Oct. 21

A laboratory notebook is critical to document research that may form the basis of a patentable invention. An accurate record can show who made the invention, the contributions of each inventor, and how the invention was made. Senior Technology Development Manager Michele Gunness will lead this seminar to present updates on patent law and best practices to maintain your laboratory notebook to assist your attorney when preparing a patent application and providing support to your … Read More

TTBD announces 2014 award winners

On Monday, October 6, Technology Transfer and Business Development (TTBD) hosted the 2014 TTBD Awards to recognize OHSU researchers who had technologies licensed or optioned in the last fiscal year as well as those who brought in top dollars from industry to support their research. The ceremony drew an enthusiastic crowd to the Portland State University lecture hall at the new Collaborative Life Sciences Building. We’d like to congratulate all of the researchers who were recognized at this year’s … Read More

Orexigen featured in the Portland Business Journal

You may have read that a drug from an OHSU startup received FDA approval last month. In 2003, OHSU’s office of Technology Transfer & Business Development (TTBD) created a start-up company called Orexigen Therapeutics, Inc., with Michael Cowley, then a neuroscience researcher at the Oregon National Primate Research Center. Cowley’s work looks at the appetite-regulating pathways in the brain and how these pathways are affected by obesity. Orexigen Therapeutics became public in 2007, and now the … Read More

OHSU startup Orexigen earns FDA approval

The office of Technology Transfer and Business Development is happy to announce that a drug from  Orexigen Therapeutics Inc., called Contrave, has been approved by the FDA. This drug helps with weight management, along with a reduced-calorie diet and increased physical activity, in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) who also have at least one weight-related comorbid condition. Contrave has two components: … Read More

Project funding available for biomedical commercialization, LOIs due Nov. 12

The Oregon Clinical & Translational Research Institute (OCTRI) is now accepting letters of intent to apply for its Biomedical Innovation Program. The Program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software. Via commercialization from academia to the marketplace, the objective is to move innovative technologies to clinical application, and thus to make a meaningful impact on human health. All applicants are strongly encouraged to take advantage of the Biomedical Innovation Program … Read More

TTBD Inventor Spotlight: Michael P. Hutchens, M.D., M.A.

The office of Technology Transfer & Business Development would like to highlight a particularly innovative or note worthy OHSU inventor and invention at the university. This quarter, our office would like to congratulate Michael P. Hutchens, M.D., M.A., for his work on the “Disinfection device for medical access sites” and the “Anesthetic vapor delivery device” that he has created and submitted to our office. Dr. Michael Hutchens is an assistant professor in the Department of … Read More

OCTRI announces 2014 Biomedical Innovation Program award recipients

The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of four research awards through its Biomedical Innovation Program. The Program cultivates and selects promising translational projects that develop new biomedical devices, diagnostics, and software. Via commercialization from academia to the marketplace, the objective is to move innovative technologies to clinical application, and thus to make a meaningful impact on human health. The Biomedical Innovation Program is a collaboration between OCTRI and OHSU … Read More

Tech Transfer Newsletter: Summer 2014

Check out the latest news in the office of Technology Transfer & Business Development (TTBD) In this issue, we discuss:  OHSU’s partnership with the Allegory Venture Partners – Learn about OHSU’s effort to accelerate venture investment in life science companies in Oregon Changes in Patent Law Section 101 – Read how changes from the U.S. Patent and Trademark Office could affect your invention’s patentability The TTBD Internship Program – TTBD’s new internship program allows students the opportunity … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives